Set to debut in Europe, the dressing is made from biosynthetic cellulose and designed to reduce downtime and risk after procedures like microneedling and laser therapy.
JeNaCell, an Evonik company, will debut epicite CALM, a medical-grade post-treatment dressing made from biosynthetic cellulose, at the Aesthetic & Anti-Aging Medicine World Congress in Monaco from March 27–29, designed to promote recovery following laser, light, and energy-based aesthetic procedures, including fractional CO2 lasers and radiofrequency microneedling.
epicite CALM will be certified under European Medical Device Regulation standards. It offers a safe, sterile, and hypoallergenic option that promotes wound healing while improving patient safety and comfort.
“Biosynthetic cellulose is a material showing superb versatility. Drawing on the extensive clinical experience in treating burns and chronic wounds with products from the epicite family, we are very pleased to offer epicite CALM to medical professionals in aesthetics to improve patient outcomes,” says Dana Kralisch, PhD, general manager of JeNaCell, in a release.
The Evonik company is a specialist in producing medical-grade products for advanced wound care. A hydro-active wound dressing, epicite CALM is designed to create a moist wound environment that promotes healing and minimizes downtime following aesthetic treatments that utilize energy-based technologies, such as CO2 lasers and radiofrequency microneedling.
These procedures enhance collagen production and address signs of aging. However, their intensity can create wounds comparable to minor burns. With some technologies penetrating the dermis up to 7mm, practitioners may face liability risks when using non-medical-grade products on compromised skin.
Made in Germany under cleanroom conditions, epicite calm is designed as an option for treatment-prone skin and surgical wounds. The product is crafted from natural biosynthetic cellulose, ensuring it is non-occlusive, hypoallergenic, and free from fragrances, preservatives, and parabens.
“epicite CALM will support medical professionals in enhancing their aftercare protocols to meet medical quality standards. We’re looking forward to partnering with distributors in Europe and internationally to help us bring this exceptional product to patients,” says Julia Born, business development and strategic marketing manager at Evonik Health Care, in a release.
Photo caption: epicite CALM
Photo credit: Evonik
